Brief: Transcode Therapeutics Receives Notice Of Award From National Institutes Of Health (Nih)
05/04/2023 12:18
April 5 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS RECEIVES NOTICE OF AWARD FROM
NATIONAL
INSTITUTES OF HEALTH (NIH) FOR THIRD YEAR OF GRANT TO SUPPORT
CLINICAL EVALUATION OF TTX-MC138
* TRANSCODE THERAPEUTICS RECEIVES NOTICE OF AWARD FROM
NATIONAL
INSTITUTES OF HEALTH (NIH) FOR THIRD YEAR OF GRANT TO SUPPORT
CLINICAL EVALUATION OF TTX-MC138
Source text for Eikon: ID:nGNXb6rL15
Further company coverage: RNAZ.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors